SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending following a Q3 earnings beat driven by strong AI and 3nm chip demand, leading to raised guidance and bullish sentiment. The community is focused on TSMC's critical role in powering the AI revolution and its increasing production capacity. Some investors suggest studying Poet technology while others discuss geopolitical risks.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ ($LAES) is trending due to a recently announced $200 million direct offering, sparking discussions around the company's growth prospects and potential share dilution. The community is weighing the significance of institutional investment via the offering against concerns about its impact on share value, with some pointing to upcoming catalysts like a CEO keynote and satellite launch. Others are drawing parallels to similar situations with other quantum stocks, hoping for a similar upward trajectory.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors react to potential catalysts, including a raised price target and discussion of the company's role in AI, particularly following news of a deal with OpenAI and Oracle. Community members are actively debating whether AMD can sustain its recent gains relative to key competitors like Nvidia, with some highlighting TSM earnings as a potential indicator. Bullish sentiment seems to be building around AMD's prospects in the AI chip market, though some caution against overvaluation.

Microvast Holdings, Inc. is an advanced battery technology company. It engages in the business of designing, developing, and manufacturing battery components and systems primarily for electric commercial vehicles and utility-scale energy storage systems. The company was founded by Yang Wu on October 12, 2006 and is headquartered in Stafford, TX.

Microvast Holdings Inc

MVST is trending as investors discuss its undervaluation compared to peers in the battery sector, highlighting its profitability and revenue growth. Community members are pointing to potential catalysts like upcoming earnings, solid-state battery developments, and expansion plans, leading to speculation of institutional buying and a potential short squeeze. Bullish sentiment is fueled by the stock hitting new 52-week highs, with many anticipating a continued upward trajectory.

Troll's Wife

$TROLGA is gaining attention as the 'wife' token of $TROLL, sparking community interest and speculative buying. Discussions revolve around its potential for a moonshot, with many highlighting its low market cap and community-driven momentum. The token is primarily traded on Phantom Wallet, with community members drawing comparisons to previous meme coin surges.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending due to a lawsuit filed by GIC concerning revenue practices from several years ago, sparking concerns about potential financial implications. The community is actively debating the validity and impact of the lawsuit, with some viewing it as a buying opportunity amidst market manipulation, while others express worry about the short-term effects. Despite the legal noise, many investors remain focused on NIO's delivery numbers and its battery swap expansion plans, believing profitability is still on the horizon.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company is trending as investors react to news of a terminated U.S. Department of Energy grant, leading to significant price volatility. The community is actively discussing the impact of this development on the company's financial outlook and whether the company will be able to move forward, with some speculating about a potential government equity stake. Despite the negative news, many are still bullish on ABAT's long-term potential in the battery technology and lithium recycling sector, particularly as a play to reduce reliance on foreign suppliers.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending due to positive sentiment around robust AI spending, highlighted by TSMC's better-than-expected profit jump and guidance. Community members are discussing SMCI's potential as a key supplier for AI infrastructure, including possible partnerships with major players and its presence in new data center projects. Investors are also noting technical indicators, such as cup and handle patterns, while weighing short interest data.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to its launch of a new platform for menopause and perimenopause care, sparking discussions about the potential for significant revenue growth. The high short float is also fueling speculation of a potential short squeeze, with community members actively monitoring trading patterns and expressing bullish sentiment. Some traders are closely watching key resistance levels, anticipating a breakout that could drive the stock to new highs.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros (OMER) is trending following news of a deal with Novo Nordisk for its rare disease drug, potentially worth up to $2.1 billion, which has triggered a surge in trading volume and price. The community is discussing the potential for a short squeeze and the stock's long-term value, with some highlighting upcoming milestones and analyst upgrades. Some traders are considering profit-taking strategies while others remain bullish, anticipating further upside based on the deal's details.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference

2seventy bio, Inc. (Nasdaq: TSVT), announced today that members of the management team will participate in a fireside chat at the upcoming TD Cowen 45th Annual Healthcare Conference on March 5, 2025...

2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results

2seventy bio, Inc. (Nasdaq: TSVT) today provided full-year Abecma (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). We are pleased to see...

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress

2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for the third quarter ended September 30, 2024. We are very pleased to report 42% sequential growth in...

2seventy bio Earnings Preview

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference

2seventy bio, Inc. (Nasdaq: TSVT) will announce its third quarter 2024 financial results on Tuesday, November 12, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can...

TSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the Firm

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 2seventy bio, Inc. (2seventy bio or the Company) (NASDAQ: TSVT). Investors who...

2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.

2seventy bio Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

TSVT
2seventy bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TSVT News

TSVT2seventy bio Inc